Early Echocardiographic Indicators of Pulmonary Vascular Disease in Preterm Infants at Risk for Bronchopulmonary Dysplasia
Pediatric Cardiology · 2026
DOI: 10.1007/s00246-025-04079-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Cardiology, 2026. Verfasst von Valentina Gava Chakr und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Universidade Federal do Rio Grande do Sul, Newborn Section, Hospital de Clínicas de Porto Alegre, Rua Silva Jardim 1155 # 7…. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Echocardiography, Pulmonary Artery, Hypertension, Pulmonary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Themen: Neonatologie
Abstract (Originalsprache)
Premature infants, particularly those with bronchopulmonary dysplasia (BPD), experience significant disruptions in pulmonary vascular development, increasing their risk of pulmonary vascular disease (PVD). Objectives were to identify early subclinical changes in echocardiographic indices of pulmonary hemodynamics and right ventricular (RV) function at 7-10 days of age (T0) in neonates who develop BPD or die before 36 weeks postmenstrual age (PMA), compared to neonates without BPD. Additionally, to determine whether late changes in echocardiographic are present at 36-40 weeks PMA (T1) in those with BPD. In this prospective cohort study, preterm infants less than 33 weeks of gestation underwent serial echocardiography to evaluate indices of pulmonary hemodynamics and RV function, including pulmonary artery acceleration time (PAAT) and tricuspid annular plane systolic excursion (TAPSE). Among 104 preterm infants, 22 developed BPD. None met echocardiographic criteria for pulmonary hypertension based on tricuspid regurgitation jet velocity (TRJV). At T0, infants with BPD or who died before 36 weeks PMA had significantly lower PAAT values after adjustment for gestational age and birth weight (52.8 vs. 67.0 milliseconds). By T1, PAAT and TAPSE were similar between groups. However, paired comparisons from T0 to T1 revealed significant increases in PAAT, TAPSE, and s' values in both groups as they matured. Early echocardiographic assessment of pulmonary hemodynamics and RV function can identify subclinical pulmonary vascular remodeling in infants with BPD. A multiparametric approach may improve early identification of pulmonary vascular remodeling, especially when TRJV is inconclusive.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Universidade Federal do Rio Grande do Sul, Newborn Section, Hospital de Clínicas de Porto Alegre, Rua Silva Jardim 1155 # 701, Porto Alegre, RS, 90450-071, Brazil.
- Department of Pediatrics, Universidade Federal do Rio Grande do Sul, Newborn Section, Hospital de Clínicas de Porto Alegre, Rua Silva Jardim 1155 # 701, Porto Alegre, RS, 90450-071, Brazil. rprocianoy@gmail.com.
Zitieren
APA
Chakr, V. G., Silveira, R. C., da Rosa Pauletto, L., Luchese, S., Barrios, P. M. M., Estrada, V. B., Cappellaro, C. R., de Freitas Horn, M. E., & Procianoy, R. S. (2026). Early Echocardiographic Indicators of Pulmonary Vascular Disease in Preterm Infants at Risk for Bronchopulmonary Dysplasia. Pediatric Cardiology. https://doi.org/10.1007/s00246-025-04079-x
Vancouver
Chakr VG, Silveira RC, da Rosa Pauletto L, Luchese S, Barrios PMM, Estrada VB, et al. Early Echocardiographic Indicators of Pulmonary Vascular Disease in Preterm Infants at Risk for Bronchopulmonary Dysplasia. Pediatric Cardiology. 2026. doi:10.1007/s00246-025-04079-x
BibTeX
@article{Chakr2026,
author = {Chakr, Valentina Gava and Silveira, Rita C and da Rosa Pauletto, Lívia and Luchese, Stelamaris and Barrios, Patrícia Martins Moura and Estrada, Vanessa Bustamante and Cappellaro, Carolina Real and de Freitas Horn, Maria Eduarda and Procianoy, Renato S},
title = {Early Echocardiographic Indicators of Pulmonary Vascular Disease in Preterm Infants at Risk for Bronchopulmonary Dysplasia},
journal = {Pediatric Cardiology},
year = {2026},
doi = {10.1007/s00246-025-04079-x}
}
EUVIMED